Organ transplantation in children

Area of Science:

• Pediatric Medicine
• Surgical Innovation
• Immunosuppression Therapy

Background:

• Organ transplantation has revolutionized pediatric medicine, offering life-saving interventions.
• Kidney transplantation is well-established, with over 2000 children receiving grafts.
• Liver and cardiac transplantations are increasingly viable options for pediatric patients.

Purpose of the Study:

• To review the current status and outcomes of pediatric organ transplantation.
• To highlight the impact of advancements like cyclosporin on graft survival and patient rehabilitation.
• To discuss the challenges and future directions in pediatric transplantation.

Main Methods:

• Review of existing data on kidney, liver, and cardiac transplantations in children.
• Analysis of graft survival rates, patient survival, and long-term complications.
• Evaluation of the role of cyclosporin in improving outcomes.

Main Results:

• Kidney graft survival exceeds 85% at 1 year, with patient survival above 95%.
• Living-related donor kidney grafts show even better outcomes.
• Cyclosporin improves long-term growth and reduces complications in pediatric transplant recipients.
• Liver and cardiac transplantations demonstrate promising survival rates, though donor availability remains a challenge.

Conclusions:

• Pediatric organ transplantation, particularly kidney, liver, and heart, offers significant benefits for children with end-stage organ disease.
• Cyclosporin has dramatically improved long-term outcomes, enhancing graft survival and patient quality of life.
• Continued research and donor coordination are crucial for expanding access and improving results in pediatric transplantation.